Signal Transduction and Targeted Therapy
| Discipline | |
|---|---|
| Language | English |
| Edited by |
|
| Publication details | |
| History | 2016–present |
| Publisher | |
| Frequency | Continuous |
| Yes | |
| 40.8 (2023) | |
| Standard abbreviations | |
| ISO 4 | Signal Transduct. Target. Ther. |
| Indexing | |
| ISSN | 2095-9907 (print) 2059-3635 (web) |
| LCCN | 2016243461 |
| OCLC no. | 1026877558 |
| Links | |
Signal Transduction and Targeted Therapy is a multidisciplinary peer-reviewed open access scientific journal covering biomedical research with a particular focus on signal transduction and its application to the drug development process. It was established in 2016 and is published by Nature Research. The editors-in-chief are Carlo M. Croce (Ohio State University), Kang Zhang (Macau University of Science and Technology), and Yu-Quan Wei (West China Medical Center). According to the Journal Citation Reports, the journal has a 2023 impact factor of 40.8.[1]
Abstract & Indexing
[edit]- Science Citation Index Expanded
- BIOSIS
- Open Access Journals (DOAJ)[2]
- MEDLINE[3]
- PubMed Central (PMC)
- Scopus
References
[edit]- ^ "Signal Transduction and Targeted Therapy". 2023 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2023.
- ^ IndexHub. "DOAJ Indexed Journals". IndexHub. Retrieved 22 December 2024.
- ^ Medline. "Journals Recently Accepted for Inclusion in MEDLINE". MEDLINE. Retrieved 22 December 2024.
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |